Ypsomed and Medical Technology and Devices (MTD) have completed the sale of the pen needle and blood glucose monitoring (BGM) systems business. Switzerland-based Ypsomed develops and manufactures injection and infusion systems for self-medication and a renowned diabetes specialist. MTD is a consumer health group owning a portfolio of global brands with a leading position across...
FlashNews:
Parliament approves an extra CHF4 billion for the Swiss army
Zurich city police raid illegal gambling establishment
UEFA Champions League: Atletico Madrid – RB Leipzig Pre-Match Information
Swiss rail freight records minor setback in the first half of 2024
Watch Exports Return to Growth in August — in Value, Not Units
SECO: Swiss economic growth sluggish in 2024, moderate recovery expected in 2025 – Action Forex
Switzerland’s economic growth in 2024 to be ‘considerably’ below average – SECO
Swiss Government Sees Sharp Drop in Inflation Rate Next Year
Switzerland returns to Afghanistan despite Taliban recognition issues
NSP vs UI Dream11 Prediction Today Match 8 Uttarakhand T20 League 2024
Undiscovered Gems in Switzerland: Top 3 Stocks for September 2024
Swiss High Growth Tech Stocks To Watch: ALSO Holding And 2 More
Swiss High Growth Tech Stocks To Watch: ALSO Holding And 2 More
Swiss Dividend Stocks: Julius Bär Gruppe And 2 More On The SIX Swiss Exchange
Switzerland Punishes Mirabaud For “Serious” Compliance Violations
UCL: Cameron Carter-Vickers excels, Auston Trusty debuts in Celtic romp – SBI Soccer
Atlético de Madrid – RB Leipzig: A new era in the Champions League
RB Leipzig ready for hostile atmosphere at Atletico
Poulter ‘too far removed’ to be Ryder Cup captain
Home » Roberto de Bonis